Atlas Arteria is an infrastructure operations business based in Australia. Atlas Arteria shares (ALX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Atlas Arteria has a trailing 12-month revenue of around $140.1 million. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Atlas Arteria, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose or you can see our list of the best share trading platforms in Australia. Then follow these steps.
Our top pick for
Best for day trading
Our top pick for
Education & learning
Our top pick for
Low commission
| 52-week range | $4.68 - $5.8427 |
|---|---|
| 50-day moving average | $5.0986 |
| 200-day moving average | $5.3158 |
| Target price | $5.56 |
| PE ratio | 23.8571 |
| Dividend yield | $0.4 (7.98%) |
| Earnings per share (TTM) | $0.21 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$5.01
| 1 week (2024-09-05) | 0.80% |
|---|---|
| 1 month (2024-08-15) | -3.65% |
| 3 months (2024-06-14) | 4.16% |
| 6 months (2024-03-15) | -4.21% |
| 1 year (2023-09-15) | -16.50% |
|---|---|
| 2 years (2022-09-15) | -31.35% |
| 3 years (2021-09-15) | -24.21% |
| 5 years (2019-09-13) | -34.59% |
Valuing Atlas Arteria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Atlas Arteria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Atlas Arteria's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Atlas Arteria shares trade at around 24x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Atlas Arteria's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $62.7 million (£32 million).
The EBITDA is a measure of a Atlas Arteria's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $140.1 million |
|---|---|
| Gross profit TTM | $368.7 million |
| Return on assets TTM | -0.06% |
| Return on equity TTM | 3.7% |
| Profit margin | 214.28% |
| Book value | 4.194 |
| Market capitalisation | $7.3 billion |
TTM: trailing 12 months
Dividend payout ratio: 194.17% of net profits
Recently Atlas Arteria has paid out, on average, around 194.17% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.98% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Atlas Arteria shareholders could enjoy a 7.98% return on their shares, in the form of dividend payments. In Atlas Arteria's case, that would currently equate to about A$0.4 per share.
Atlas Arteria's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 March 2024 (the "ex-dividend date").
Over the last 12 months, Atlas Arteria's shares have ranged in value from as little as $4.68 up to $5.8427. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Atlas Arteria's is 0.782. This would suggest that Atlas Arteria's shares are less volatile than average (for this exchange).
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
We used Finder's proprietary algorithm to find the 10 best stocks under $10 on the ASX.
We used Finder's proprietary algorithm to find Australian-listed companies that have strong fundamentals and have a share price under $5.
Here are our algorithm-selected 20 Aussie stocks worth watching in 2024.
Here's what investors should know before adding AI stocks to their portfolios.
Find out the different ways you can invest in the S&P 500 index from Australia.
Saxo Invested allows you to trade over 60,000 instruments on 50 global stock exchanges and provides lower commissions for active traders.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Compare share trading apps to find out which app has all the tools and resources you need to reach your investment goals.
A dividend is the distribution of some of a company's profits that are paid regularly to its shareholders.
Follow these tips to find the best share trading platform for you.